152 related articles for article (PubMed ID: 12505598)
21. Dose-dense paclitaxel for advanced ovarian cancer.
Zeng YC; Wu R; Xu ZG; Chi F
Lancet; 2010 Jan; 375(9711):280-1; author reply 281. PubMed ID: 20109950
[No Abstract] [Full Text] [Related]
22. Combination regimens of paclitaxel and the platinum drugs as first-line regimens for ovarian cancer.
Ozols RF
Semin Oncol; 1995 Dec; 22(6 Suppl 15):1-6. PubMed ID: 8643963
[TBL] [Abstract][Full Text] [Related]
23. Phase II study of weekly paclitaxel plus 24-h continuous infusion 5-fluorouracil, folinic acid and 3-weekly cisplatin for the treatment of patients with advanced gastric cancer.
Honecker F; Kollmannsberger C; Quietzsch D; Haag C; Schroeder M; Spott C; Hartmann JT; Baronius W; Hempel V; Kanz L; Bokemeyer C
Anticancer Drugs; 2002 Jun; 13(5):497-503. PubMed ID: 12045461
[TBL] [Abstract][Full Text] [Related]
24. Medical therapy of advanced malignant epithelial tumours of the ovary.
Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
[TBL] [Abstract][Full Text] [Related]
25. A phase I study of weekly topotecan and Paclitaxel in previously treated epithelial ovarian carcinoma patients.
Homesley H; Benigno B; Williams J; Vaccarello L
Gynecol Oncol; 2002 Nov; 87(2):171-7. PubMed ID: 12477447
[TBL] [Abstract][Full Text] [Related]
26. Weekly carboplatin and paclitaxel is safe, active, and well tolerated in recurrent ovarian cancer cases of Japanese women previously treated with cisplatin-containing multidrug chemotherapy.
Kikuchi A; Sakamoto H; Yamamoto T
Int J Gynecol Cancer; 2005; 15(1):45-9. PubMed ID: 15670296
[TBL] [Abstract][Full Text] [Related]
27. Carboplatin/paclitaxel versus cisplatin/paclitaxel as first-line chemotherapy in advanced ovarian cancer: an interim analysis of a randomized phase III trial of the Arbeitsgemeinschaft Gynäkologische Onkologie Ovarian Cancer Study Group.
du Bois A; Lück HJ; Meier W; Möbus V; Costa S; Richter B; Warm M; Bauknecht T; Schröder W; Olbricht S; Nitz U; Jackisch C
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-44-S15-52. PubMed ID: 9346222
[TBL] [Abstract][Full Text] [Related]
28. [Combined chemotherapy with weekly paclitaxel and carboplatin for recurrent and refractory epithelial ovarian cancer--phase I study].
Misawa A; Yasuda M
Gan To Kagaku Ryoho; 2006 Oct; 33(10):1445-52. PubMed ID: 17033235
[TBL] [Abstract][Full Text] [Related]
29. Advanced ovarian cancer: phase III randomized study of sequential cisplatin-topotecan and carboplatin-paclitaxel vs carboplatin-paclitaxel.
Hoskins P; Vergote I; Cervantes A; Tu D; Stuart G; Zola P; Poveda A; Provencher D; Katsaros D; Ojeda B; Ghatage P; Grimshaw R; Casado A; Elit L; Mendiola C; Sugimoto A; D'Hondt V; Oza A; Germa JR; Roy M; Brotto L; Chen D; Eisenhauer EA
J Natl Cancer Inst; 2010 Oct; 102(20):1547-56. PubMed ID: 20937992
[TBL] [Abstract][Full Text] [Related]
30. Carboplatin versus cisplatin in ovarian cancer.
Alberts DS
Semin Oncol; 1995 Oct; 22(5 Suppl 12):88-90. PubMed ID: 7481869
[TBL] [Abstract][Full Text] [Related]
31. Paclitaxel and carboplatin: a phase I study in advanced non-small cell lung cancer.
Paccagnella A; Favaretto A; Oniga F; Ossana L
Semin Oncol; 1996 Dec; 23(6 Suppl 16):76-9. PubMed ID: 9007128
[TBL] [Abstract][Full Text] [Related]
32. Sequential combination of paclitaxel-carboplatin and paclitaxel-liposomal doxorubicin as a first-line treatment in patients with ovarian cancer. A multicenter phase II trial.
Potamianou A; Androulakis N; Papakotoulas P; Toufexi H; Latoufis C; Kouroussis C; Christofilakis C; Xenidis N; Georgoulias V; Polyzos A
Oncology; 2005; 69(4):348-53. PubMed ID: 16293974
[TBL] [Abstract][Full Text] [Related]
33. Chronic administration of single weekly paclitaxel in heavily pretreated ovarian cancer patients.
Yamamoto K; Oogi S; Inoue H; Kudoh K; Kita T; Kikuchi Y
Curr Med Chem; 2004 Feb; 11(4):425-8. PubMed ID: 14965223
[TBL] [Abstract][Full Text] [Related]
34. What is the role of dose-dense therapy?
van der Burg ME; van der Gaast A; Vergote I; Burger CW; van Doorn HC; de Wit R; Stoter G; Verweij J
Int J Gynecol Cancer; 2005; 15 Suppl 3():233-40. PubMed ID: 16343238
[TBL] [Abstract][Full Text] [Related]
35. Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial.
Katsumata N; Yasuda M; Takahashi F; Isonishi S; Jobo T; Aoki D; Tsuda H; Sugiyama T; Kodama S; Kimura E; Ochiai K; Noda K;
Lancet; 2009 Oct; 374(9698):1331-8. PubMed ID: 19767092
[TBL] [Abstract][Full Text] [Related]
36. A phase II double-blind randomized study of the simultaneous administration of recombinant human interleukin-6 and recombinant human granulocyte colony-stimulating factor following paclitaxel and carboplatin chemotherapy in patients with advanced epithelial ovarian cancer.
Hochster H; Speyer JL; Mandeli JP; Runowicz C; Wadler S; Berk G; Wallach R; Holland JF
Gynecol Oncol; 1999 Mar; 72(3):292-7. PubMed ID: 10053098
[TBL] [Abstract][Full Text] [Related]
37. Phase II trial of weekly single-agent paclitaxel in platinum/paclitaxel-refractory ovarian cancer.
Markman M; Hall J; Spitz D; Weiner S; Carson L; Van Le L; Baker M
J Clin Oncol; 2002 May; 20(9):2365-9. PubMed ID: 11981009
[TBL] [Abstract][Full Text] [Related]
38. Feasibility of dose-dense paclitaxel/carboplatin therapy in elderly patients with ovarian, fallopian tube, or peritoneal cancer.
Bun S; Yunokawa M; Ebata T; Shimomura A; Shimoi T; Kodaira M; Yonemori K; Shimizu C; Fujiwara Y; Kato T; Makino Y; Hayashi Y; Tamura K
Cancer Chemother Pharmacol; 2016 Oct; 78(4):745-52. PubMed ID: 27522647
[TBL] [Abstract][Full Text] [Related]
39. Dose-escalated paclitaxel in 1-hour infusion with a fixed dose of cisplatin in previously untreated advanced ovarian cancer: a phase II trial of the Spanish Group for Ovarian Cancer.
Cervantes A; Mendiola C; del Campo JM; Massuti B; Casado A; Escobedo A; Moyano A; Ojeda B; Poveda A; Benito D
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-40-S15-43. PubMed ID: 9346221
[TBL] [Abstract][Full Text] [Related]
40. A phase II study of paclitaxel and carboplatin with a biweekly schedule in patients with epithelial ovarian cancer: Gynecologic Cancer Network trial.
Yoneyama K; Konishi H; Yahata T; Fujita K; Aoki Y; Doi D; Matsushima T; Kodama S; Honma S; Kato H; Nakayama H; Kamoi S; Asakura H; Takeshita T; Tanaka K
J Nippon Med Sch; 2014; 81(1):28-34. PubMed ID: 24614392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
